Singapore's Dr. Kavitha Sothirasan Joins Japan's 7th Special Seminar for Appropriate Helmet Therapy

Advancing Global Standards for Appropriate Cranial Assessment via Historic Japan-Singapore Exchange

株式会社ジャパン・メディカル・カンパニー

一般社団法人ヘルメット治療評価認定機構認定、株式会社ジャパン・メディカル・カンパニー主催の「第7回位置的診療開始に対するヘルメット適正治療研修会」にシンガポール最大の女性・小児医療専門病院であるKK Women’s and Children’s Hospitalの小児科医Dr.Kavithaを招聘、乳児の頭蓋変形とヘルメット治療に関する特別演題を発表

TOKYO – Dr. Kavitha Sothirasan of KK Women's and Children's Hospital (KKH) participated

as Distinguished Guest Speaker at the "7th Special Seminar for Appropriate Helmet Therapy"
on Dec 14, 2025.

About the Seminar: Organized by Japan Medical Company Inc. (JPMC) and certified by The

Japan Council for Quality Helmet Treatment, this is Japan’s leading forum for cranial care.

This historic session welcomed Dr. Kavitha as inaugural international speaker, convening

over100 physicians and surgeons for a high-level exchange on "Appropriate Cranial Medical

Examinations" and "Appropriate Helmet Therapy."

Significance of Exchange

  • Historic Exchange: Dr. Kavitha enabled profound know-how transfer between Japan and

    Singapore.

  • Standardizing Quality: Drives regional standardization through collaboration with leading

    specialists.

Insights from Principal Instructors & Chairpersons

Prof. Akira Gomi, Director/Head of Surgical Services, Baby's Head Reshaping Clinic (Tokyo

Nihonbashi); Vice Director, Japan Cranial Medical Examination and Treatment Society

(Former Prof., Pediatric Neurosurgery, Jichi Children's Medical Center Tochigi): "Diagnosis is

the cornerstone. This milestone reinforced the importance of a universal foundation for

examination and therapy through the sharing of Singapore’s clinical initiatives."

Prof. Shigeharu Hosono, Representative Director, Japan Council for Quality Helmet

Treatment; Representative Director, Japan Cranial Medical Examination and Treatment

Society (Former Prof., Pediatrics/Perinatal Medicine, Saitama Medical Center, Jichi Medical

University): "This marks a vital step in rooting prevention in Japan, catalyzing an exchange

of standards for cranial examinations."

Prof. Yoshiyuki Takahashi, Professor, Dept. of Pediatrics, Nagoya University Graduate School

of Medicine: "Accurate differentiation between pathological and positional deformities is vital.

Diverse cases from both nations allow global evidence-based guidance through appropriat

medical checkups."

Prof. Koji Yoshimoto, Professor, Dept. of Neurosurgery, Graduate School of Medical Sciences,

Kyushu University: "We reaffirmed the necessity of clinical judgment and discussed evolving

strategies like combined surgical-helmet therapy alongside international peers."

Special Remarks from the Distinguished Guest Speaker

Dr. Kavitha Sothirasan

(Staff Physician, Dept. of Neonatology, KKH)

Participating in this seminar was an extremely meaningful and valuable experience for

me. The lectures by authoritative professors in the field were highly suggestive,

underpinned by abundant clinical experience in appropriate cranial medical

examinations and appropriate helmet therapy. Furthermore, the opportunity to

interact with numerous experts well-versed in cranial pathology allowed me to gain a

deeper understanding of the characteristics of the infant cranium and the

biomechanics of effective correction. There is no doubt that this seminar has

deepened my knowledge regarding assessment methods, formulation of treatment

plans, and long-term prognosis in cranial deformity management. I am convinced that

the many important clinical insights gained here will significantly contribute to

improving the quality of patient care at the KKH PlagioCentre (KK Hospital Head Shape

Clinic), the first national specialized clinical center in Singapore dedicated to the

assessment and treatment of cranial asymmetry. The operation by Japan Medical

Company was also extremely smooth, making it a wonderful seminar full of intellectual

stimulation. I earnestly hope that such opportunities for study will be provided again in

the future, and I look forward to deepening the collaboration between Japanese

doctors and Japan Medical Company.

Background on KKH-JPMC Collaboration (Previously Issued Press Release) KKH and JPMC

have been strengthening collaboration to support evidence-based cranial care and the

standardization of Appropriate Cranial Medical Examinations and Helmet Therapy.:

https://prtimes.jp/main/html/rd/p/000000102.000046445.html

About KK Women’s and Children’s Hospital

KK Women’s and Children’s Hospital has evolved since its founding in 1858 as a leader in

obstetrics, gynecology, pediatrics, and neonatology in Singapore. Currently, this 830-bed

hospital serves as a tertiary referral center providing services for the management of

high-risk conditions in women and children. A team of approximately 500 specialists

adopts a multidisciplinary, holistic treatment approach, leveraging the latest medical

innovations and technologies to provide the best possible care. As an academic medical

center, KKH believes that world-class clinical training and research are essential for raising

medical standards, embracing a culture of innovation while achieving world-class clinical

leadership. KKH is also a major teaching hospital for the Duke-NUS Medical School, Yong Loo

Lin School of Medicine, and Lee Kong Chian School of Medicine in Singapore. The hospital

also operates Singapore's largest specialist training programs in Obstetrics & Gynecology

and Pediatrics. KKH continuously raises clinical standards in Singapore while caring for the

provision of a comfortable hospital experience so that patients can receive seamless

services and enjoy compassionate care in a healing environment.

About Japan Medical Company

Japan Medical Company is a manufacturing venture that innovates the shape of medicine

using cutting-edge 3D printing technology. Preceded by Ohno Kogyo, a steel manufacturer

founded in 1897, the company has continued to grow based on manufacturing technology

and spirit cultivated over 130 years. In 1999, the company introduced reverse engineering

using additive manufacturing technology (3D printing) and obtained a patent for a

manufacturing method for human bone models such as auditory ossicles. In the field of 3D

models for preoperative simulation, this led to the development of numerous preoperative

case models and educational training models. Currently, these are used for hands-on training

using our models in preoperative simulations and board certification examinations, primarily

in the fields of Neurosurgery and Otorhinolaryngology. In 2012, the company jointly

developed "Aimet," the first domestically produced cranial remolding helmet, with

neurosurgeons, and became independent as Japan Medical Company in 2018. Currently,

the company develops, manufactures, and sells cranial remolding helmets "Qurum Fit" and

"Qurum," the "Baby's Head Shape Measurement App" which can easily measure the degree

of infant cranial deformity, and the "metto app" which supports helmet therapy, aiming to

create new value in the medical field. With a track record of over 20,000 cumulative cases

using helmets, we will strive to further expand awareness of helmet therapy and work on

disseminating the concept of cranial shape correction itself and disease enlightenment.

Company Overview

Company Name: Japan Medical Company Inc.

Established: May 2018

CEO: Hideaki Ono

Business Activities: Development, manufacturing, and sales of medical devices and medical

simulation models

URL: https://japanmedicalcompany.co.jp

Japan Medical Company Press Release List:

https://prtimes.jp/main/html/searchrlp/company_id/46445

Media Contact: Mizuho Yanagimoto Corporate Design Office Japan Medical Company

Phone: +81-3-5829-8342

Email: choice@japanmedicalcompany.co.jp

すべての画像


会社概要

URL
https://japanmedicalcompany.co.jp/
業種
医療・福祉
本社所在地
東京都中央区東日本橋2-24-12 東日本橋槇町ビル2F
電話番号
03-5829-8342
代表者名
大野秀晃
上場
未上場
資本金
2323万円
設立
2018年05月